16 September 2021
Article credit: ANMJ
The Australian Government has secured 25 million doses of Moderna Australia’s COVID-19 vaccine Spikevax (elasomeran) also called the mRNA-1273 vaccine following provisional approval by the Australian Therapeutic Goods Administration (TGA).
The Moderna vaccine will shore up and diversify Australia’s supply and also afford opportunity for potential booster shots. Of the addition of the Moderna vaccine means that there are now four COVID-19 vaccines with TGA provisional approval (these include Pfizer/BioNtech, Oxford/AstraZeneca and Janssen-Cilag (Johnson & Johnson which is provisionally approved but not yet included in Australia’s COVID-19 vaccination program).
It is important to understand that the provisional approval process is extremely rigorous and that greater scrutiny and detail is demanded from drug companies to comply with the TGA’s strict requirements.1
Click
here to read the full article.